English
Back
Open Account
Futubull Options Sir
wrote a column · Feb 25 17:52

Earnings and Options Strategy | With the boost from the commercial aerospace sector, what should investors focus on in Rocket Lab's earnings report?

The rising star in commercial aerospace $Rocket Lab (RKLB.US)$ will release its Q4 and full-year 2025 earnings report after the US stock market closes on February 26 (Thursday), followed by an earnings call.
This earnings report carries significant weight, as the market primarily wants to verify two things:First, whether the Q4 earnings guidance can be achieved as expected; second, whether the development pace of the new launch vehicle, Neutron, can be clarified.
Q4 earnings are highly likely to meet expectations, with the earnings call being the real main battleground
For Q4 2025 earnings, Rocket Lab has provided quite clear guidance: revenue is expected to fall within the range of $170 million to $180 million, with GAAP gross margin remaining between 37% and 39%. Currently, the market consensus closely aligns with the upper-middle range of the company’s guidance: revenue is projected at approximately $178.2 million, with earnings per share (EPS) estimated at around -$0.098.
The rising star in commercial aerospace $Rocket Lab (RKLB.US)$ will release its Q4 and full-year 2025 earnings report after the US stock market closes on February 26 (Thursday), followed by an earnings call. This earnings report carries significant weight, as the market primarily wants to verify two things:First, whether the Q4 earnings guidance can be achieved as expected; second, whether the development pace of the new launch vehicle, Neutron, can be clarified. Q4 earnings are highly likely to meet expectations, with the earnings call being the real main battleground For Q4 2025 earnings, Rocket Lab has provided quite clear guidance: revenue is expected to fall within the range of $170 million to $180 million, with GAAP gross margin remaining between 37% and 39%. Currently, the market consensus closely aligns with the upper-middle range of the company’s guidance: revenue is projected at approximately $178.2 million, with earnings per share (EPS) estimated at around -$0.098. Thus, the focus of earnings night is no longer simply about whether there is growth, but rather three deeper litmus tests: 1. Whether actual revenue can approach the upper limit of the guidance range, andthe extent to which next-quarter guidance exceeds expectations, as well as the status of new orders. 2. Whether gross margin can stabilize at a high level., raising the visibility of future net profit expectations 3. Most importantly, whether the management can give a strong boost to the pace of business in 2026 - this includesThe R&D progress of Neutronand the actual delivery status of defense orders, as well as...
Thus, the focus of earnings night is no longer simply about whether there is growth, but rather three deeper litmus tests:
1. Whether actual revenue can approach the upper limit of the guidance range, andthe extent to which next-quarter guidance exceeds expectations, as well as the status of new orders.
2. Whether gross margin can stabilize at a high level., raising the visibility of future net profit expectations
3. Most importantly, whether the management can give a strong boost to the pace of business in 2026 - this includesThe R&D progress of Neutron, the status of actual deliveries for defense orders, and market sensitivity around cash burn and potential financing risks.
Expectation game: Major events intertwined, with market sentiment repeatedly torn
Since 2026, RKLB’s share price has experienced a fairly volatile journey, hitting a record high near the hundred-dollar mark in mid-January, then retreating all the way down, trading in the $65-80 range before earnings.
Looking back at key events, in mid-January, amid the commercial aerospace boom, Rocket Lab (RKLB) first underwent a round of valuation reshaping. Morgan Stanley pointed out that the core rationale for being bullish on RKLB lies in the company's excellent launch execution capabilities, as well asan increasingly clear path toward entering the medium-lift market, which directly ignited investor sentiment. Subsequently, multiple Wall Street institutions revised their forecasts upward. Notably, Bank of America doubled its price target from $60 to $120 and explicitly incorporated the potentialsector-wide enthusiasm triggered by a SpaceX IPO into its bullish thesis。
The rising star in commercial aerospace $Rocket Lab (RKLB.US)$ will release its Q4 and full-year 2025 earnings report after the US stock market closes on February 26 (Thursday), followed by an earnings call. This earnings report carries significant weight, as the market primarily wants to verify two things:First, whether the Q4 earnings guidance can be achieved as expected; second, whether the development pace of the new launch vehicle, Neutron, can be clarified. Q4 earnings are highly likely to meet expectations, with the earnings call being the real main battleground For Q4 2025 earnings, Rocket Lab has provided quite clear guidance: revenue is expected to fall within the range of $170 million to $180 million, with GAAP gross margin remaining between 37% and 39%. Currently, the market consensus closely aligns with the upper-middle range of the company’s guidance: revenue is projected at approximately $178.2 million, with earnings per share (EPS) estimated at around -$0.098. Thus, the focus of earnings night is no longer simply about whether there is growth, but rather three deeper litmus tests: 1. Whether actual revenue can approach the upper limit of the guidance range, andthe extent to which next-quarter guidance exceeds expectations, as well as the status of new orders. 2. Whether gross margin can stabilize at a high level., raising the visibility of future net profit expectations 3. Most importantly, whether the management can give a strong boost to the pace of business in 2026 - this includesThe R&D progress of Neutronand the actual delivery status of defense orders, as well as...
However, by late January, the development risks of the Neutron project were once again brought to the forefront. The company disclosed that the first-stage tank of Neutron had ruptured during hydrostatic testing and stated it is currently assessing the impact of this incident on the overall timeline, with specific details to be updated during the Q4 earnings call. For RKLB, the impact of such news is highly direct: the market will quickly recalculate the first flight window for Neutron, the subsequent commercialization schedule, and concerns about cost overruns and accelerated cash burn.
Fortunately, a few days later, Rocket Lab stabilized sentiment with tangible hardware milestones, announcing that the reusable fairing for Neutron had arrived at the Virginia launch site and officially entered the subsequent inspection and testing process. Such progress can indeed provide some relief, but ultimately, the true flexibility in valuation still hinges onwhether management can present a more definitive version of the Neutron timeline during the earnings call。
SpaceX’s 'valuation halo' serves as both an imaginative upside and a stringent benchmark
One external variable that cannot be ignored in the commercial aerospace sector this year is the valuation trend of SpaceX and the strong pull of its potential IPO on overall sector sentiment. In early February, Elon Musk announced the merger of SpaceX with xAI, resulting in a combined valuation of approximately $1.25 trillion. Reports also noted that the market’s feverish imagination regarding a potential SpaceX IPO could very likelypush its valuation above $1.5 trillion。
This major news instantly ignited the US commercial space stocks. Rocket Lab is currently one of the hottest commercial aerospace stocks in the US market, and its stock price has been driven up accordingly.
The impact of this valuation anchor effect on Rocket Lab typically follows two paths:
– Positive premium effect: As SpaceX's valuation continues to rise in the private market, investors will be more generous in assigning higher valuation premiums to companies in the same sector listed on public markets. This premium becomes even more justified when Rocket Lab’s narrative logic has successfully expanded from being a single launch service provider to becoming a participant in defense and space systems.
– Differentiated scrutiny pressure: On the flip side, the higher SpaceX's valuation goes, the more the market will scrutinize Rocket Lab under the same framework. Whether it's the timeline, cost, and success rate of medium-sized reusable rockets or the health of its order structure and the resilience of its cash flow, everything will be examined more rigorously. Any delays at the Neutron node or signs of upward cost revisions could trigger an even sharper retraction in its valuation.
The rising star in commercial aerospace $Rocket Lab (RKLB.US)$ will release its Q4 and full-year 2025 earnings report after the US stock market closes on February 26 (Thursday), followed by an earnings call. This earnings report carries significant weight, as the market primarily wants to verify two things:First, whether the Q4 earnings guidance can be achieved as expected; second, whether the development pace of the new launch vehicle, Neutron, can be clarified. Q4 earnings are highly likely to meet expectations, with the earnings call being the real main battleground For Q4 2025 earnings, Rocket Lab has provided quite clear guidance: revenue is expected to fall within the range of $170 million to $180 million, with GAAP gross margin remaining between 37% and 39%. Currently, the market consensus closely aligns with the upper-middle range of the company’s guidance: revenue is projected at approximately $178.2 million, with earnings per share (EPS) estimated at around -$0.098. Thus, the focus of earnings night is no longer simply about whether there is growth, but rather three deeper litmus tests: 1. Whether actual revenue can approach the upper limit of the guidance range, andthe extent to which next-quarter guidance exceeds expectations, as well as the status of new orders. 2. Whether gross margin can stabilize at a high level., raising the visibility of future net profit expectations 3. Most importantly, whether the management can give a strong boost to the pace of business in 2026 - this includesThe R&D progress of Neutronand the actual delivery status of defense orders, as well as...
Options Trading: Structured strategies outperform unilateral participation
If you want to participate in Rocket Lab’s options game during earnings week, you must first understand how the market is pricing it before choosing tools. According to current market data, the implied expected volatility for Rocket Lab is approximately 14%, which is relatively high and higher than last quarter.。
The rising star in commercial aerospace $Rocket Lab (RKLB.US)$ will release its Q4 and full-year 2025 earnings report after the US stock market closes on February 26 (Thursday), followed by an earnings call. This earnings report carries significant weight, as the market primarily wants to verify two things:First, whether the Q4 earnings guidance can be achieved as expected; second, whether the development pace of the new launch vehicle, Neutron, can be clarified. Q4 earnings are highly likely to meet expectations, with the earnings call being the real main battleground For Q4 2025 earnings, Rocket Lab has provided quite clear guidance: revenue is expected to fall within the range of $170 million to $180 million, with GAAP gross margin remaining between 37% and 39%. Currently, the market consensus closely aligns with the upper-middle range of the company’s guidance: revenue is projected at approximately $178.2 million, with earnings per share (EPS) estimated at around -$0.098. Thus, the focus of earnings night is no longer simply about whether there is growth, but rather three deeper litmus tests: 1. Whether actual revenue can approach the upper limit of the guidance range, andthe extent to which next-quarter guidance exceeds expectations, as well as the status of new orders. 2. Whether gross margin can stabilize at a high level., raising the visibility of future net profit expectations 3. Most importantly, whether the management can give a strong boost to the pace of business in 2026 - this includesThe R&D progress of Neutronand the actual delivery status of defense orders, as well as...
Meanwhile,Rocket Lab’s implied volatility ahead of earnings is also gradually rising, currently around 99%, sitting at the 79th percentile level.
The rising star in commercial aerospace $Rocket Lab (RKLB.US)$ will release its Q4 and full-year 2025 earnings report after the US stock market closes on February 26 (Thursday), followed by an earnings call. This earnings report carries significant weight, as the market primarily wants to verify two things:First, whether the Q4 earnings guidance can be achieved as expected; second, whether the development pace of the new launch vehicle, Neutron, can be clarified. Q4 earnings are highly likely to meet expectations, with the earnings call being the real main battleground For Q4 2025 earnings, Rocket Lab has provided quite clear guidance: revenue is expected to fall within the range of $170 million to $180 million, with GAAP gross margin remaining between 37% and 39%. Currently, the market consensus closely aligns with the upper-middle range of the company’s guidance: revenue is projected at approximately $178.2 million, with earnings per share (EPS) estimated at around -$0.098. Thus, the focus of earnings night is no longer simply about whether there is growth, but rather three deeper litmus tests: 1. Whether actual revenue can approach the upper limit of the guidance range, andthe extent to which next-quarter guidance exceeds expectations, as well as the status of new orders. 2. Whether gross margin can stabilize at a high level., raising the visibility of future net profit expectations 3. Most importantly, whether the management can give a strong boost to the pace of business in 2026 - this includesThe R&D progress of Neutronand the actual delivery status of defense orders, as well as...
In this pricing environment, more practical option strategy deployments may include:
– Bullish perspective: If you are primarily betting that Q4 revenue will reach the upper end of the guidance and believe that the earnings call will stabilize expectations around Neutron, then using a Bull Call Spread is typically more suitable than directly buying naked Calls. This approach not only helps manage costs effectively but also reduces the impact of implied volatility (IV) pullback.
– Bearish perspective: If your main concern is a significant delay in Neutron’s timeline or higher-than-expected cash burn with the potential for another equity financing round, a Bear Put Spread would be a more prudent choice. This allows you to capture gains in the downward price movement while avoiding the risk of overpaying for expensive premiums tied to maintaining IV levels.
The rising star in commercial aerospace $Rocket Lab (RKLB.US)$ will release its Q4 and full-year 2025 earnings report after the US stock market closes on February 26 (Thursday), followed by an earnings call. This earnings report carries significant weight, as the market primarily wants to verify two things:First, whether the Q4 earnings guidance can be achieved as expected; second, whether the development pace of the new launch vehicle, Neutron, can be clarified. Q4 earnings are highly likely to meet expectations, with the earnings call being the real main battleground For Q4 2025 earnings, Rocket Lab has provided quite clear guidance: revenue is expected to fall within the range of $170 million to $180 million, with GAAP gross margin remaining between 37% and 39%. Currently, the market consensus closely aligns with the upper-middle range of the company’s guidance: revenue is projected at approximately $178.2 million, with earnings per share (EPS) estimated at around -$0.098. Thus, the focus of earnings night is no longer simply about whether there is growth, but rather three deeper litmus tests: 1. Whether actual revenue can approach the upper limit of the guidance range, andthe extent to which next-quarter guidance exceeds expectations, as well as the status of new orders. 2. Whether gross margin can stabilize at a high level., raising the visibility of future net profit expectations 3. Most importantly, whether the management can give a strong boost to the pace of business in 2026 - this includesThe R&D progress of Neutronand the actual delivery status of defense orders, as well as...
– Short volatility perspective: If you believe the market is pricing volatility too high and want to take the role of an option seller, it’s advisable to adopt a risk-defined structure (e.g., Iron Condor/Iron Butterfly strategies). For high-volatility names like Rocket Lab, the risk of selling naked Straddles or wide Strangles can become extremely difficult to control in the event of price gaps.
The rising star in commercial aerospace $Rocket Lab (RKLB.US)$ will release its Q4 and full-year 2025 earnings report after the US stock market closes on February 26 (Thursday), followed by an earnings call. This earnings report carries significant weight, as the market primarily wants to verify two things:First, whether the Q4 earnings guidance can be achieved as expected; second, whether the development pace of the new launch vehicle, Neutron, can be clarified. Q4 earnings are highly likely to meet expectations, with the earnings call being the real main battleground For Q4 2025 earnings, Rocket Lab has provided quite clear guidance: revenue is expected to fall within the range of $170 million to $180 million, with GAAP gross margin remaining between 37% and 39%. Currently, the market consensus closely aligns with the upper-middle range of the company’s guidance: revenue is projected at approximately $178.2 million, with earnings per share (EPS) estimated at around -$0.098. Thus, the focus of earnings night is no longer simply about whether there is growth, but rather three deeper litmus tests: 1. Whether actual revenue can approach the upper limit of the guidance range, andthe extent to which next-quarter guidance exceeds expectations, as well as the status of new orders. 2. Whether gross margin can stabilize at a high level., raising the visibility of future net profit expectations 3. Most importantly, whether the management can give a strong boost to the pace of business in 2026 - this includesThe R&D progress of Neutronand the actual delivery status of defense orders, as well as...
Long-term contrarian positioning: If you are bullish on the company’s long-term prospects and care more about milestones being met by 2026 as well as ongoing developments related to SpaceX’s IPO, you can treat the earnings release as a “filter.” Patiently wait until the earnings call clarifies the future path for Neutron before deciding whether to enter into longer-term bullish structures (or use calendar/diagonal spreads to “sell” short-term elevated volatility and lower your overall cost basis).
Overall, when analyzing Rocket Lab’s earnings report, focus on three key pieces of information—revenue, gross margin, and Neutron progress—to observe how the market reacts.
If you'd like more inspiration regarding options strategies, you can easily access it via the mobile app or the new desktop platform using the following path!
The rising star in commercial aerospace $Rocket Lab (RKLB.US)$ will release its Q4 and full-year 2025 earnings report after the US stock market closes on February 26 (Thursday), followed by an earnings call. This earnings report carries significant weight, as the market primarily wants to verify two things:First, whether the Q4 earnings guidance can be achieved as expected; second, whether the development pace of the new launch vehicle, Neutron, can be clarified. Q4 earnings are highly likely to meet expectations, with the earnings call being the real main battleground For Q4 2025 earnings, Rocket Lab has provided quite clear guidance: revenue is expected to fall within the range of $170 million to $180 million, with GAAP gross margin remaining between 37% and 39%. Currently, the market consensus closely aligns with the upper-middle range of the company’s guidance: revenue is projected at approximately $178.2 million, with earnings per share (EPS) estimated at around -$0.098. Thus, the focus of earnings night is no longer simply about whether there is growth, but rather three deeper litmus tests: 1. Whether actual revenue can approach the upper limit of the guidance range, andthe extent to which next-quarter guidance exceeds expectations, as well as the status of new orders. 2. Whether gross margin can stabilize at a high level., raising the visibility of future net profit expectations 3. Most importantly, whether the management can give a strong boost to the pace of business in 2026 - this includesThe R&D progress of Neutronand the actual delivery status of defense orders, as well as...
That’s all for today.Finally, here’s a small perk for fellow investors—welcome to claim it!Options Beginner's Package（*This promotion is available exclusively to HK invited users; click to learn more.Event Details Rules >>）
Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.Read more
Thumbs Up
5
72K Views
Report
Comments
Write a Comment...
5
8